PTEROIS THERAPEUTICS
Turning nature’s secrets into hope.
Covering more than 70% of our planet’s surface, the oceans are home to an immense and largely unexplored biodiversity — including bacteria, algae, sponges, corals, mollusks, and countless other organisms.Many of these life forms thrive in extreme environments — intense pressure, temperature variations, or high salinity — and, in doing so, produce unique bioactive molecules essential for their survival. These molecules hold tremendous potential for innovation in biotechnology and medicine.
01
Revolutionizing Cancer Treatment from the Depths of the Ocean
Pterois Therapeutics is a pioneering marine biotechnology company harnessing the untapped potential of the ocean’s biodiversity to fight cancer. Our breakthrough research focuses on bioactive molecules derived from the venom of Pterois volitans (lionfish) — a unique natural source of highly selective, potent therapeutic agents. By transforming a harmful invasive species into a medical resource, we turn a global ecological challenge into a life-saving opportunity.
02
Next-Generation Therapies with Unmatched Selectivity
Our proprietary extraction and purification technologies enable the isolation of phospholipase A2 enzymes with remarkable anticancer activity and high therapeutic indices. These bioactive proteins target tumor cells with precision, triggering apoptosis while sparing healthy tissues. This innovative mechanism of action opens new therapeutic pathways for drug-resistant cancers and delivers hope to patients with limited treatment options.
03
From Natural Venom to Advanced Biopharmaceuticals
Pterois Therapeutics is at the forefront of translational oncology. Our pipeline spans natural venom-derived compounds, recombinant protein production, and next-generation mRNA therapeutics — all based on the same powerful biological mechanism. Each platform is designed to accelerate drug development, enhance safety, and enable personalized cancer therapies that can adapt to evolving clinical needs.
04
Sustainability Meets Innovation
Our mission goes beyond medicine. By valorizing an invasive marine species, we contribute to the restoration of fragile coral ecosystems while creating economic value for coastal communities. This dual impact — environmental and medical — reflects our commitment to sustainable innovation and aligns with the United Nations Sustainable Development Goals on health, life below water, and innovation.
ABOUT US
Pterois Therapeutics is a cutting-edge marine biotechnology company dedicated to transforming the hidden power of the ocean into breakthrough cancer therapies. Our mission is to harness the extraordinary bioactive potential of marine organisms — particularly the venom of Pterois volitans (lionfish) — to develop innovative, highly selective treatments for some of the most challenging cancers.
At the heart of our research lies a pioneering platform that isolates and purifies phospholipase A2 enzymes with remarkable anticancer properties. These molecules target tumor cells with exceptional precision, inducing apoptosis while preserving healthy tissue — a revolutionary approach that opens new horizons for patients resistant to conventional therapies.
Our work bridges nature and science: by valorizing an invasive marine species known for its ecological impact, we not only create life-saving medicines but also contribute to ocean biodiversity restoration and sustainable marine resource management.
From natural venom-derived compounds to recombinant proteins and mRNA-based therapeutics, Pterois Therapeutics is redefining the future of oncology — one molecule at a time. Guided by innovation, sustainability, and a deep commitment to human health, we strive to turn nature’s most potent defenses into powerful allies in the fight against cancer.
Why Pterois Therapeutics?
From Ocean Venom to Cancer Innovation
Pterois Therapeutics transforms the venom of Pterois volitans into breakthrough anticancer therapies with unmatched selectivity. Our unique platform targets tumor cells precisely, overcoming resistance where conventional treatments fail. With a diversified pipeline — from natural bioactives to recombinant proteins and mRNA therapeutics — we deliver innovative solutions while contributing to marine ecosystem restoration. A rare convergence of science, sustainability, and impact.
01
Breakthrough Science & Unmet Medical Needs
We develop next-generation anticancer therapies based on marine bioactive molecules with unique mechanisms of action, capable of targeting tumor cells with high selectivity — offering new solutions where conventional treatments fail.
02
Diversified, Scalable Innovation Pipeline
Our platform spans natural venom-derived compounds, recombinant proteins, and mRNA therapeutics, ensuring multiple clinical applications, scalable production, and strong commercialization potential.
03
Sustainability with Real-World Impact
By valorizing an invasive marine species into life-saving medicines, we combine environmental restoration with medical innovation, creating a rare triple value: scientific, societal, and ecological.
ALWAYS CONNECTED
Global Scientific Collaboration
We actively collaborate with leading research institutes, universities, and oncology centers worldwide — ensuring that our discoveries are continuously enriched by cutting-edge science and multidisciplinary expertise.
Open Innovation & Knowledge Sharing
Pterois Therapeutics believes in open dialogue with the scientific and medical community. We regularly share insights, data, and breakthroughs to accelerate the development of next-generation therapies and build a strong innovation ecosystem.
Partners, Patients, and Progress
From strategic industry partnerships to patient advocacy networks, we stay connected to those who matter most. Our commitment is to turn collaboration into impact — delivering real therapeutic advances faster and more effectively.